Patricia Sand, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 600 S 2nd St, Central Point, OR 97502 Phone: 541-535-6239 |
News Archive
Regeneron Pharmaceuticals, Inc. today announced that Bayer HealthCare's Japanese subsidiary, Bayer Yakuhin, Ltd., received approval for EYLEA (aflibercept) Injection by the Ministry of Health, Labour and Welfare (MHLW) in Japan for the treatment of patients with macular edema secondary to retinal vein occlusion (RVO).
By taking folic acid before pregnancy or during the first few weeks after conception, women can markedly lower the risk of neural tube defects in their offspring; the defects commonly manifest themselves as a debilitating health condition known as spina bifida. The neural tube is fully developed 22 to 28 days after conception
A greater exposure to air pollution at the very start of life was associated with a detrimental effect on people's cognitive skills up to 60 years later, the research found.
Hemispherx Biopharma, Inc. announced its financial results for the three months ended June 30, 2010. The net loss (including non-cash expenses) for the 2nd fiscal quarter was approximately $3,676,000 or $0.03 per share compared to a loss of approximately $3,870,000 or $0.04 per share for the same period in 2009.
› Verified 3 days ago